Blafar

Blafar develops innovative injectable hydrogels and bio-inks from multifunctional extracellular matrix-based and synthetic biopolymers for bio-applications such as cell drug delivery and 3D bioprinting. They provide a series of advanced injectable hydrogel systems as the optimal microenvironments for customized cell culture and regenerative medicine.

<div><p>Blafar develops innovative injectable hydrogels and bio-inks from multifunctional extracellular matrix-based and synthetic biopolymers for bio-applications such as cell drug delivery and 3D bioprinting. They provide a series of advanced injectable hydrogel systems as the optimal microenvironments for customized cell culture and regenerative medicine.</p></div>

Enabling supply of biologically safe tissues and organs using next-gen printing tech

Bioprinting

<div>
  <p>
    Blafar develops innovative injectable hydrogels and bio-inks from multifunctional extracellular matrix-based and synthetic biopolymers for bio-applications such as cell drug delivery and 3D bioprinting. They provide a series of advanced injectable hydrogel systems as the optimal microenvironments for customized cell culture and regenerative medicine.
  </p>
</div>


<div>
  <p>
    3D Bioprinting Solutions is a biotechnological research laboratory that develops and produces 3D bioprinters and bioprinting materials.
  </p>
</div>


3D Bioprinting Solutions

<div>
  <p>
    3Dynamic Systems
  </p>
</div>


3Dynamic Systems

<div>
  <p>
    A.D.A.M. (Advanced Development of Additive Manufacturing) is a biotech company that provides 3D-bioprinting services on demand. A.D.A.M. uses its proprietary 3D-printing technology and patented materials to manufacture bioresorbable and biodegradable patient-specific implants (primarily, bone implants). By designing and building an on-demand tissue manufacturing solution, we have been pioneering this technology as a service model to effectively address a complex problem. The business model will allow patients to have their tissue modelled – using the MRI/CAT scans stored on the digital platform – and, subsequently, 3D-printed and implanted in certified clinics. We reached our main achievement to date in August, as the FDA responded to our Q-Sub (Pre-Submission) confirming our 510(k) regulatory path eligibility. This response means that no human trials and required and a decrease in time to market from 5 years to 1.5-2 years.    Additionally, we have been accepted to join Technology Incubation Program at University of Connecticut in Farmington, CT. We have just moved our main office there as TIP offers state of the art research facilities and resources to its member companies. Our intention is to complete the required animal studies there.    Finally, we have secured our lead investor for the upcoming Series A round.
  </p>
</div>


A.D.A.M.

<div>
  <p>
    Advanced BioMatrix is a leader in the life science of three-dimensional (3D) applications for tissue culture, cell assay, bioprinting, and cell proliferation. The company's products are recognized as the standard for purity, functionality, and consistency. Advanced BioMatrix has extensive expertise in production, isolation, purification, lyophilization, cell culture, and testing of proteins, adhesion peptides, attachment factors, bio-inks, substrate rigidity, and other 3D matrix products. Their expertise and knowledge are being employed to assure that their products are of the highest quality, consistent from lot to lot, and easy to use for research customers. The company is located in the San Diego region – one of the world’s largest life science and biotechnology clusters. Advanced BioMatrix has been manufacturing and delivering high-quality products for research uses and applications for over 10 years. Advanced BioMatrix transforms science to a new level of discovery by providing advanced technologies through innovative 3D matrix products.
  </p>
</div>


Advanced Biomatrix

<div>
  <p>
    Advanced Solutions Life Sciences provides solutions for living organisms, molecular biology, and biotechnology.
  </p>
</div>


Advanced Solutions Life Sciences

3D printing enables bioprinting devices, which rely on a similar design and operating model

Startups in this hub are able to customize the bioprinted models to suit each patient

AI/ML is used in the design and optimization of 3D models that can be bioprinted

Companies that are developing materials and bioinks, that can be used in bioprinting devices. This includes material technologies and nanofibers.

Blafar

Bioprinting

Key stats

EDGE Insights

Print your heart out: Bioprinting and the future of organs

Company Brief

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless